drugset / Trial / NCT02582047
Influenza Vaccine and Pneumococcal Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
Previous studies have demonstrated the immunogenicity and safety of the co-administration of the trivalent inactivated influenza vaccine (IIV3) with the polysaccharide pneumococcal vaccine (PPV) or pneumococcal conjugate vaccine (PCV). However, there is no direct comparison study that evaluates the immunogenicity and safety of IIV3 given concomitantly with PCV13 or PPV23 in the elderly. This study is intended to compare the immunogenicity and safety of concomitant administration in the elderly subjects.
Timeline
- Start
- 2012-10
- Primary completion
- 2012-12
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GCflu | Unknown | — | — |
| Comparator | Pneumovax 23 | Vaccine | — | — |
| Comparator | Prevnar 13 | Vaccine | — | — |